For the year ending 2025-12-31, LAB has $567,754K in assets. $143,463K in debts. $120,863K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 120,863 | |||
| Short-term investments | 66,712 | |||
| Accounts receivable, net | 13,431 | |||
| Inventory | 19,981 | |||
| Prepaid expenses and other current assets | 4,871 | |||
| Current assets held for sale | 228,406 | |||
| Total current assets | 454,264 | |||
| Property and equipment, gross | 66,537 | |||
| Less accumulated depreciation and amortization | 48,162 | |||
| Construction-in-progress | 900 | |||
| Property and equipment, net | 19,275 | |||
| Operating lease right-of-use asset, net | 26,732 | |||
| Other non-current assets | 3,154 | |||
| Long-term investments | 25,701 | |||
| Deferred tax asset, non-current | 38,628 | |||
| Non-current assets held for sale | 0 | |||
| Total assets | 567,754 | |||
| Accounts payable | 5,407 | |||
| Accrued liabilities | 29,783 | |||
| Operating lease liabilities, current | 5,490 | |||
| Deferred revenue, current | 38,949 | |||
| Deferred grant income, current | 3,046 | |||
| Current liabilities held for sale | 25,633 | |||
| Total current liabilities | 108,308 | |||
| Convertible notes, non-current | 299 | |||
| Deferred tax liability | 810 | |||
| Operating lease liabilities, non-current | 25,038 | |||
| Deferred revenue, non-current | 3,503 | |||
| Deferred grant income, non-current | 4,290 | |||
| Other non-current liabilities | 1,215 | |||
| Total liabilities | 143,463 | |||
| Common stock 0.001 par value, 600,000 shares authorized at december 31, 2025 and 2024 404,961 and 396,110 shares issued at december 31, 2025 and 2024, respectively 386,381 and 377,530 shares outstanding at december 31, 2025 and 2024, respectively | 404 | |||
| Additional paid-in capital | 1,732,393 | |||
| Accumulated other comprehensive income (loss) | -1,492 | |||
| Accumulated deficit | -1,260,547 | |||
| Treasury stock at cost 18,580 shares at december 31, 2025 and 2024 | 46,467 | |||
| Total stockholders' equity | 424,291 | |||
| Total liabilities and stockholders' equity | 567,754 | |||
STANDARD BIOTOOLS INC. (LAB)
STANDARD BIOTOOLS INC. (LAB)